Developing a Radiopharmaceutical Clinical Operations Strategy
- Reducing transit times whilst also ensuring regulatory adherence
- Reviewing the current regulatory and safety protocols – what is currently unclear?
- Investigating strategies to mitigate supply chain disruptions for isotopes with short half-lives